Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 25991 | 266 | 29.1 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 1311 | 2 | PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL | 8520 |
| 25991 | 1 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE//15 PGDH//15 HYDROXYPROSTAGLANDIN DEHYDROGENASE 15 PGDH | 266 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE | authKW | 1296475 | 9% | 47% | 24 |
| 2 | 15 PGDH | authKW | 499974 | 5% | 31% | 14 |
| 3 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE 15 PGDH | authKW | 153058 | 1% | 67% | 2 |
| 4 | NUCLEIC SEQUENCE | authKW | 153058 | 1% | 67% | 2 |
| 5 | PROSTAGLANDIN DEHYDROGENASE | authKW | 151038 | 2% | 26% | 5 |
| 6 | 12S HYDROXYHEPTADECA 5Z 8E10E TRIENOIC ACID | authKW | 114794 | 0% | 100% | 1 |
| 7 | 15 HYDROPROSTAGLANDIN DEHYDROGENASE 15 PGDH | authKW | 114794 | 0% | 100% | 1 |
| 8 | 15 KETE | authKW | 114794 | 0% | 100% | 1 |
| 9 | 15 KETO 6Z 8Z 11Z 13E EICOSATETRAENOIC ACID | authKW | 114794 | 0% | 100% | 1 |
| 10 | 15 OXOETE | authKW | 114794 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Biochemistry & Molecular Biology | 659 | 42% | 0% | 113 |
| 2 | Endocrinology & Metabolism | 418 | 16% | 0% | 43 |
| 3 | Biophysics | 391 | 15% | 0% | 39 |
| 4 | BIOLOGY, MISCELLANEOUS | 294 | 1% | 0% | 2 |
| 5 | MEDICINE, MISCELLANEOUS | 287 | 1% | 0% | 2 |
| 6 | Cell Biology | 205 | 16% | 0% | 42 |
| 7 | Pharmacology & Pharmacy | 181 | 17% | 0% | 46 |
| 8 | Oncology | 165 | 15% | 0% | 39 |
| 9 | Medicine, General & Internal | 32 | 7% | 0% | 18 |
| 10 | Medicine, Research & Experimental | 26 | 5% | 0% | 13 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLIN KOLKWITZ | 114794 | 0% | 100% | 1 |
| 2 | DIGEST TEST | 114794 | 0% | 100% | 1 |
| 3 | ESTUDIOS FARMACOL BOT CEFY | 114794 | 0% | 100% | 1 |
| 4 | FRAUENKLIN ALBERT WEITZER STR 33 | 114794 | 0% | 100% | 1 |
| 5 | IHF HORMONE FERTILITY | 114794 | 0% | 100% | 1 |
| 6 | MODELING HLTH RER | 114794 | 0% | 100% | 1 |
| 7 | PHARM MED CHEM PHARMACOL | 114794 | 0% | 100% | 1 |
| 8 | SURGUROPHARMACOL ENDOUROL | 114794 | 0% | 100% | 1 |
| 9 | CANC UK COLORECTAL TUMOUR BIOL GRP | 91829 | 2% | 20% | 4 |
| 10 | MED ONCOLSTATE BIOTHER YCANC | 57396 | 0% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 8381 | 3% | 1% | 8 |
| 2 | PROSTAGLANDINS | 7800 | 4% | 1% | 10 |
| 3 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 7204 | 5% | 0% | 14 |
| 4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 4059 | 3% | 0% | 8 |
| 5 | PROSTAGLANDINS AND MEDICINE | 2019 | 1% | 1% | 2 |
| 6 | CANCER PREVENTION RESEARCH | 1495 | 2% | 0% | 4 |
| 7 | CLINICAL RESPIRATORY PHYSIOLOGY-BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE | 720 | 0% | 1% | 1 |
| 8 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 662 | 4% | 0% | 10 |
| 9 | KOSMICHESKAYA BIOLOGIYA I AVIAKOSMICHESKAYA MEDITSINA | 585 | 1% | 0% | 2 |
| 10 | METHODS IN ENZYMOLOGY | 558 | 3% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | TAI, HH , (2011) PROSTAGLANDIN CATABOLIC ENZYMES AS TUMOR SUPPRESSORS.CANCER AND METASTASIS REVIEWS. VOL. 30. ISSUE 3-4. P. 409-417 | 34 | 59% | 27 |
| 2 | TAI, HH , ENSOR, CM , TONG, M , ZHOU, HP , YAN, FX , (2002) PROSTAGLANDIN CATABOLIZING ENZYMES.PROSTAGLANDINS & OTHER LIPID MEDIATORS. VOL. 68-9. ISSUE . P. 483-493 | 35 | 61% | 164 |
| 3 | LOU, LH , JING, DD , LAI, YX , LU, YY , LI, JK , WU, K , (2012) 15-PGDH IS REDUCED AND INDUCES APOPTOSIS AND CELL CYCLE ARREST IN GASTRIC CARCINOMA.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 18. ISSUE 10. P. 1028-1037 | 24 | 69% | 10 |
| 4 | NA, HK , PARK, JM , LEE, HG , LEE, HN , MYUNG, SJ , SURH, YJ , (2011) 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE AS A NOVEL MOLECULAR TARGET FOR CANCER CHEMOPREVENTION AND THERAPY.BIOCHEMICAL PHARMACOLOGY. VOL. 82. ISSUE 10. P. 1352-1360 | 32 | 41% | 20 |
| 5 | TAI, HH , CHO, H , TONG, M , DING, Y , (2006) NAD(+)-LINKED 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE: STRUCTURE AND BIOLOGICAL FUNCTIONS.CURRENT PHARMACEUTICAL DESIGN. VOL. 12. ISSUE 8. P. 955-962 | 30 | 46% | 64 |
| 6 | LI, LH , YANG, F , WANG, XJ , HU, J , YANG, LB , TANG, CM , WU, YH , MIAO, K , LIU, R , SHOU, T , (2014) EFFECT OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE GENE ON THE PROLIFERATION OF GASTRIC CANCER CELL MURINE FORESTOMACH CARCINOMA.EXPERIMENTAL AND THERAPEUTIC MEDICINE. VOL. 7. ISSUE 1. P. 290-294 | 12 | 80% | 3 |
| 7 | CASTRO-SANCHEZ, L , AGRA, N , IZQUIERDO, CL , MOTINO, O , CASADO, M , BOSCA, L , MARTIN-SANZ, P , (2013) REGULATION OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE EXPRESSION IN HEPATOCELLULAR CARCINOMA.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 45. ISSUE 11. P. 2501 -2511 | 20 | 45% | 4 |
| 8 | LU, DD , HAN, C , WU, T , (2013) 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE-DERIVED 15-KETO-PROSTAGLANDIN E-2 INHIBITS CHOLANGIOCARCINOMA CELL GROWTH THROUGH INTERACTION WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, SMAD2/3, AND TAP63 PROTEINS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 288. ISSUE 27. P. 19484-19502 | 20 | 39% | 11 |
| 9 | LU, D , HAN, C , WU, T , (2014) 15-PGDH INHIBITS HEPATOCELLULAR CARCINOMA GROWTH THROUGH 15-KETO-PGE(2)/PPAR GAMMA-MEDIATED ACTIVATION OF P21(WAF1/CIP1).ONCOGENE. VOL. 33. ISSUE 9. P. 1101-1112 | 17 | 43% | 9 |
| 10 | KIM, HR , LEE, HN , LIM, K , SURH, YJ , NA, HK , (2014) 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) INDUCES EXPRESSION OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE THROUGH ELK-1 ACTIVATION IN HUMAN BREAST CANCER MDA-MB-231 CELLS.MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. VOL. 768. ISSUE . P. 6 -15 | 20 | 38% | 0 |
Classes with closest relation at Level 1 |